2009
|
Date
|
Event
|
| Jan 11-14 |
Regulatory Affairs: Part I:The IND Phase and Part II: The CTD/NDA Phase
This course combines the two three-day courses into one extended four-day
offering. It describes the regulatory background of the IND and NDA and
provides an overview of the requirements and recommendations for preparing
and managing these applications.
Drug Information Association
Irvine, CA
USA |
| Jan 11-15 |
8th Annual DIA Conference for Contemporary Pharmacovigilance and Risk
Management Strategies
This comprehensive four-day program will address the current complexities
and controversies in pharmacovigilance and risk management throughout all
phases of development and marketed use.
Drug Information Association
Washington DC
USA |
| Jan 12-14 |
WCBP 2009
FDA co-sponsored WCBP Symposium series is the pre-eminent conference addressing the analytical development/regulatory control interface for biotechnology derived health intervention products.
CASSS
San Francisco, CA
USA |
| Feb 2-3 |
DIA’s 1st Workshop on Pre-market Evaluation of Quality and Bioavailability
Drug Information Association
Mumbai
MH
India |
| Feb 5-6 |
DIA’s 1st Workshop on Pre-market Evaluation of Quality and Bioavailability
Drug Information Association
Hyderabad
India |
| Feb 9-13 |
Excellence in Pharmacovigilance: Clinical Trials and Post Marketing
This course is designed to provide a firm grounding in key aspects of Global
Clinical and Post Marketing Safety. This five-day training course, presented
by the EMEA, is the only one of its kind.
Drug Information Association
Paris
France |
| Feb 10 |
Development of a Clinical Study Report
Introductory Course for Those Who are New to Writing or Reviewing Integrated
Clinical Study Reports
This fast-track course will teach you the latest strategies for preparing
clear, well-organized, and ICH-compliant clinical study reports.
Drug Information Association
Philadelphia, PA
USA |
| Feb 18-20 |
Essentials of Clinical Study Management
Learn the Ins-and-Outs of Study Management, the Clinical Study Environment,
and the Overall Drug Development.
Featuring an esteemed European training faculty with over 100 years of
combined experience in phase I-IV clinical trial management at big pharma,
biotechnology firms, CROs and SMEs, as well as academic clinical research
centres.
Drug Information Association
Madrid
Spain |
| Feb 18-19 |
European Regulatory Affairs
This training course will provide an excellent introduction to the European
Regulatory Procedures for personnel in regulatory
affairs, clinical research, project management and other disciplines
involved in the development of medicinal products.
Drug Information Association
Nice
France |
| Feb 25-28 |
Drug Discovery and Clinical Development in India
This conference will continue to serve as an international and neutral forum
to address current solid scientific research in India pertaining to global
development of drugs and biologics.
Drug Information Association
Mumbai
India |
| Mar 4-5 |
Implementation of GAMP 5
GAMP/ISPE Conference: "Implementation of GAMP 5", case studies and
experiences. Confirmed FDA speaker: Robert Tolefsen
GAMP/ISPE
Tampa
FL
USA |
| Mar 4-6 |
GAMP/ISPE Conference Tampa
GAMP 5 Implementation Case Studies and Experiences. Include FDA speaker
(Robert Toleffsen, who's FDA national expert on computer. He'll be
discussing risk analysis expectations.
ISPE/GAMP
Tampa
FL
USA |
| Mar 22-26 |
ACS Spring Meeting and Exposition
Salt Lake City, UT
USA |
| Mar 23-25 |
DIA 21st EuroMeeting
Drug Information Association
Berlin
Germany |
| May 11-15 |
Waters Inform 2009 Annual Informatics User Meeting
Waters Corporation
Seattle, Washington
USA |
| Jun 21-25 |
DIA 45th Annual Meeting
Drug Information Association
San Diego, CA
USA |
